Differences in Psychotropic Drug Prescribing Between Ethnic Groups of People with Dementia in the United Kingdom

References

• Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Dement J Alzheimer’s Assoc. 2013;9(1):63–75. (). doi:10.1016/j.jalz.2012.11.007
   PubMed Web of Science ®Google Scholar
• House of Commons All-Party Parliamentary Group on Dementia. Dementia Does Not Discriminate. London; 2013 Available from: https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/appg_2013_bame_report.pdf. Accessed January 05, 2020.
   Google Scholar
• Pham T, Petersen I, Walters K, et al. Trends in dementia diagnosis rates in UK ethnic groups: analysis of UK primary care data. Clin Epidemiol. 2018;10:949–960. doi:10.2147/CLEP.S15264730123007
   PubMed Web of Science ®Google Scholar
• Prince M, Knapp M, Guerchet M, et al. Dementia UK, 2nded. King's College London, London; 2014
   Google Scholar
• Cooper C, Bebbington P, McManus S, et al. The treatment of common mental disorders across age groups: results from the 2007 adult psychiatric morbidity survey. J Affect Disord. 2010;127(1–3):96–101. doi:10.1016/j.jad.2010.04.02020466432
   PubMed Web of Science ®Google Scholar
• Cooper C, Spiers N, Livingston G, et al. Ethnic inequalities in the use of health services for common mental disorders in England. Soc Psychiatry Psychiatr Epidemiol. 2013;48(5):685–692. doi:10.1007/s00127-012-0565-y22893107
   PubMed Web of Science ®Google Scholar
• Cooper C, Tandy A, Balamurali T, Livingston G. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatry. 2010;18(3):193–203. doi:10.1097/JGP.0b013e3181bf9caf20224516
   PubMed Web of Science ®Google Scholar
• Lind KE, Gray LC, Raban MZ, Georgiou A, Westbrook JI. Antidementia medication use by aged care facility residents with dementia. Int J Geriatr Psychiatry. 2019;34(7):1029–1040. doi:10.1002/(ISSN)1099-116630907450
   PubMed Web of Science ®Google Scholar
• Thorpe CT, Fowler NR, Harrigan K, et al. Racial and ethnic differences in initiation and discontinuation of antidementia drugs by medicare beneficiaries. J Am Geriatr Soc. 2016;64(9):1806–1814. doi:10.1111/jgs.1440327549029
   PubMed Web of Science ®Google Scholar
• Banerjee S. The Use of Antipsychotic Medication for People with Dementia: Time for Action. London; English Department of Health 2009 Available from: https://www.jcpmh.info/wp-content/uploads/time-for-action.pdf. Accessed Janaury 05, 2020.
   Google Scholar
• Sura S, Carnahan R, Chen H, Aparasu R. Anticholinergic drugs and health-related quality of life in older adults with dementia. J Am Pharm Assoc. 2015;55(3):282–287. doi:10.1331/JAPhA.2015.14068
   Google Scholar
• Vance J. AMDA-choosing wisely. J Am Med Dir Assoc. 2013;14(9):639–641. doi:10.1016/j.jamda.2013.07.00424011659
   PubMed Web of Science ®Google Scholar
• Blak B, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;9(4):251–255.
   Google Scholar
• Booth N. What are the read codes? Health Libr Rev. 1994;11:177–182. doi:10.1046/j.1365-2532.1994.1130177.x10139676
   PubMedGoogle Scholar
• The Kings Fund. General Practice in England: An Overview. London: The Kings Fund; 2009.
   Google Scholar
• Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. London: Croom Helm Ltd; 1987.
   Google Scholar
• Cooper C, Lodwick R, Walters K, et al. Inequalities in receipt of mental and physical healthcare in people with dementia in the UK. Age Ageing. 2016;46(3):393–400.
   Web of Science ®Google Scholar
• Maguire A, Blak B, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18(1):76–83. doi:10.1002/pds.v18:119065600
   PubMed Web of Science ®Google Scholar
• Horsfall L, Walters K, Petersen I. Identifying periods of acceptable computer usage in primary care research databases. Pharmacoepidemiol Drug Saf. 2013;22(1):64–69. doi:10.1002/pds.v22.123124958
   PubMed Web of Science ®Google Scholar
• Cai X, Campbell N, Khan B, Callahan C, Boustani M. Long-term anticholinergic use and the aging brain. Alzheimer’s Dement. 2013;9(4):377–385. doi:10.1016/j.jalz.2012.02.00523183138
   PubMed Web of Science ®Google Scholar
• Brilleman S, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract. 2013;30(2):172–178. doi:10.1093/fampra/cms06023045354
   PubMed Web of Science ®Google Scholar
• Stovring H, Pottegard A, Hallas J. Determining prescription durations based on the parametric waiting time distribution. Pharmacoepidemiol Drug Saf. 2016;25(12):1451–1459. doi:10.1002/pds.411427670969
   PubMed Web of Science ®Google Scholar
• Sterne J, White I, Carlin J, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. doi:10.1136/bmj.b239319564179
   PubMed Web of Science ®Google Scholar
• Rubin D. Inference and missing data. Biometrika. 1976;63:581–592. doi:10.1093/biomet/63.3.581
   Web of Science ®Google Scholar
• Rubin D. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons, Inc.; 1987.
   Google Scholar
• Barnard J, Rubin D. Small-sample degrees of freedom with multiple imputation. Biometrika. 1999;86:948–955. doi:10.1093/biomet/86.4.948
   Web of Science ®Google Scholar
• Tillin T, Forouhi N, Jonston D, McKeigue P, Chaturvedi N, Godsland I. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia. 2005;48(4):649–656. doi:10.1007/s00125-005-1689-315759110
   PubMed Web of Science ®Google Scholar
• Berwald S, Roche M, Adelman S, Mukadam N, Livingston G. Black African and Caribbean British communities’ perceptions of memory problems: “We Don’t Do Dementia.”. PLoS One. 2016;11(4):e0151878. doi:10.1371/journal.pone.015187827045999
   PubMed Web of Science ®Google Scholar
• Mukadam N, Cooper C, Basit B, Livingston G. Why do ethnic elders present later to UK dementia services? A qualitative study. Int Psychogeriatrics. 2011;23(07):1070–1077. doi:10.1017/S1041610211000214
   Web of Science ®Google Scholar
• Cook L, Mukherjee S, McLachlan T, Shah R, Livingston G, Mukadam N. Parity of access to memory services in London for the BAME population: a cross-sectional study. Aging Ment Heal. 2019;23(6):693–697. doi:10.1080/13607863.2018.1442413
   PubMed Web of Science ®Google Scholar
• Mukadam N, Lewis G, Mueller C, Werbeloff N, Stewart R, Livingston G. Ethnic differences in cognition and age in people diagnosed with dementia: A study of electronic health records in two large mental healthcare providers. Int J Geriatr Psychiatry. 2019;34(3):504–510. doi:10.1002/gps.504630675737
   PubMed Web of Science ®Google Scholar
• Maust D, Blow F, Wiechers I, Kales H, Marcus S. National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry. 2017;78(4):. doi:10.4088/JCP.16m10713
   Web of Science ®Google Scholar
• Lind KE, Raban MZ, Georgiou A, Westbrook JI. Duration of antipsychotic medication use by aged care facility residents with dementia. Alzheimer Dis Assoc Disord. 2019;33:331–338. doi:10.1097/WAD.000000000000033631343414
   PubMed Web of Science ®Google Scholar
• McManus S, Bebbington P, Jenkins R, Brugha T. Mental Health and Wellbeing in England: Adult Psychiatric Morbidity Survey 2014. Leeds; NHS Digital 2016Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/556596/apms-2014-full-rpt.pdf. Accessed January 05, 2020.
   Google Scholar